2020 Agenda
Monday, October 5, 2020
| 7:00 am – 7:00 pm |
BIO One-on-One Partnering Meetings open |
| 8:00 am – 5:00 pm |
Exhibit Hall Open | Networking Lounge Open |
| 9:00 am – 9:15 am |
Welcome and Opening RemarksRemarks by: |
| 9:15 am – 10:15 am |
Keynote session and Lifetime Achievement Award presentationJim Greenwood, Former President and CEO, Biotechnology Innovation Organization (BIO) Introductions by: |
| 10:15 am – 10:25 am |
Break |
| 10:25 am – 11:25 am |
SESSION ALife Sciences TrackPandemic & Risk Mitigation: A focus on preparation & resiliencyThree Maryland biotech leaders discuss how to prepare for the unforeseen and what is needed to pivot for the future. Moderator: Speakers: Entrepreneurship TrackIt Takes an EcosystemIt takes an ecosystem to generate and support entrepreneurial activities, but no two regional ecosystems are alike. A fertile entrepreneurial ecosystem is the sum of interconnected individuals, organizations and entities, a unique regional terroir that facilitates and nourishes entrepreneurial activities. Our panelists will discuss their own experience in the Biohealth Capital Region, what is unique about the Maryland ecosystem, how they have successfully leveraged local resources, tools and contacts to build and grow their business, and why they have done it in Maryland. Moderator: Speakers: |
| 11:25 am – 11:35 am |
Break |
| 11:35 am – 12:35 pm |
SESSION BLife Sciences TrackVaccine Development: Driving Partnerships in MarylandThis panel will discuss the work that each company is doing on the vaccine development front, and will highlight important partners and collaborators they have used or will be using along their path to bringing life-saving products to market. Moderator: Speakers: Entrepreneurship TrackHuman Resource as Strategy – Building a Team to Ensure Success and to Attract InvestorsAs a company progresses forward, the strategy of hiring decisions becomes paramount to their success. Value judgments must be made on how to prioritize the skills and experience necessary to attract investors. This session will discuss building a team to ensure success. It will focus on the key roles within startup companies, developing boards, what to look for when partnering with investors and other companies, and the shift of expertise when transitioning from an early stage company to a public company. Moderator: Speaker: |
| 12:35 pm – 1:50 pm |
Thought Leadership Lightning Rounds
“More Savings, More Research” BIO Business Solutions is the largest cost savings purchasing program for the life sciences industry, operated by BIO and available to members of MTC. BIO Business Solutions pools the purchasing power of thousands of life sciences companies across North America to negotiate for exclusive pricing and favorable terms on things like lab supplies, office supplies, insurance, and much more. Learn how MTC member companies can leverage the BIO Business Solutions to stretch their funding or improve their bottom line.
“The Immunology Capital Next to the Nation’s Capital: Montgomery County, MD” The epicenter for translating knowledge into previously unimaginable treatments and cures can be found in Montgomery County, Maryland next to the nation’s capital. From cell and gene therapies to vaccines, biologics and advanced biomanufacturing, global innovators with the most promising advancements in science and human health grow with us here in Maryland. In a state that’s home to the largest payer, researcher and regulator of healthcare products in the world (CMS, NIH, and FDA), Montgomery County offers access to 40,000 life sciences workers, 18 federal agency headquarters, and a prime location that features 3 international airports, extensive parkland and broad diversity in our schools and community. These resources and our prime location make Montgomery County the perfect landing spot to grow and thrive.
“Maryland Scientific Market: A 10-Year Forecast” A discussion about the expanding geography of the Maryland scientific market, major drivers, product types and cost over the next ten years.
“The Death of the Regulatory Barrier to Better Medicine” Does the development of effective drugs have to be incredibly expensive? Maybe not anymore. There is a new type of drug development emerging: Gene Therapy. The hallmark of gene therapy is the ability to edit or modify the drivers of disease at the most fundamental level, our genes. To put it simply, we now have the ability to replace a broken gene in your DNA. Those educated on the subject of gene therapy will argue that there are a thousand caveats to that sweeping statement, but those caveats are quickly eroding.
“Maintaining Continuity of Clinical Research in the era of COVID-19” COVID-19 has brought about an inflection point in our industry. Despite a brief initial slowdown in clinical trials, thousands of COVID-19 trials are on-going today, in addition to existing clinical trials. Continuing clinical research through this pandemic requires us to adopt different approaches. This session will enable you to understand what it takes to run clinical trials in this new context, where remote monitoring and virtual trials are no longer just industry buzzwords, but business as usual. |
| 2:00 pm – 3:00 pm |
Virtual Trade Delegation Panel DiscussionRegenerative Medicine & Cell Therapy Industry of Kanagawa, JapanJETRO New York Kanagawa Division Kanagawa Prefecture is one of the most dynamic life science and biotechnology hubs in Japan, home to diverse companies working on regenerative cell therapy, pharmaceuticals manufacturing, and reagent manufacturing for testing and research. This webinar will showcase the three hottest Kanagawa companies in the field of regenerative cell therapy: REPROCELL, Elixirgen Scientific, Inc. and Cyfuse Biomedical. Their deep connection to Maryland, along with Kanagawa-Maryland ties, one of the oldest US-Japan cooperative relationships, have formed a strong foundation for collaboration. Partnerships with Kanagawa affiliated companies can serve as a gateway for Maryland businesses to the vast and growing opportunities in Asian markets. Moderator: Speakers: |
| 3:00 pm – 4:00 pm |
Virtual Trade Delegation Panel DiscussionGlobal VictoriaSpeakers: |
Tuesday, October 6, 2020
| 7:00 am-7:00pm |
BIO One-on-One Partnering Meetings open |
| 8:00 am-5:00pm |
Exhibit Hall Open | Networking Lounge Open |
| 9:00 am – 10:00 am |
Keynote SpeakerFireside Chat with Senator Chris Van Hollen Join us for a fireside chat with Maryland Life Sciences CEO, Martin Rosendale, and Senator Chris Van Hollen, as they discuss the life sciences industry in Maryland, Maryland’s response to the COVID-19 pandemic and the work being done to create a more inclusive environment in industry leadership and workforce. Moderator Speaker |
| 10:00 am – 10:10 am |
Break |
| 10:10 am – 11:10 am |
SESSION CLife Sciences TrackBiomanufacturing in Maryland: Building a global footprint and maximizing the local ecosystemThe state of Maryland has over 2,700 life science firms and 500+ biotech companies. Approximately 20% of the world’s top influencers in vaccine development are in Maryland, while VC investments in life sciences companies continue to increase rapidly. In addition to the thousands of regionally anchored life sciences companies headquartered in Maryland, there are 78 federal labs driving research and innovation in the area, while many more are expanding operations in the state and advancing Maryland’s biomanufacturing footprint. This panel session will discuss biomanufacturing in the Maryland area and how the state has created a perfect formula for biomanufacturing success. Introduction by Maryland Department of Commerce Moderator Speakers
Entrepreneurship TrackBusiness Resiliency for Survival and SuccessBusiness resiliency generally implies an ability to handle unexpected, difficult situations: lack of funding, failed clinical trial, surprise FDA audit, loss of a key employee, a lawsuit, stagnant sales, etc.; but it can also mean preparedness for achieving expected goals: license in a product, raise funds, advance the product, sell the product or business, etc. In this session a panel of entrepreneurs will share advice on business resiliency based on their business experiences. Moderator Speakers |
| 11:10 am – 11:20 am |
Break |
| 11:20 am – 12:20 pm |
SESSION DLife Sciences TrackExpanding Progress and Opportunities in Gene and Cell TherapyGene and cell therapies have accrued a track record of disease treatment, IPOs on Wall Street, and transactions to large Pharma. Cures for blindness (Lebers), a deadly inherited neuronal disorder (SMA), inherited immunodeficiency (ACA-SCID and X-SCID), and cancers (AML and ALL) are early examples, but the pace of development is accelerating! Don’t miss out on the most significant future opportunities for healthcare, investment, collaboration, and career growth. Catch up on the “cutting-edge” with experts at this session. Moderator: Speaker: Entrepreneurship TrackThe Government as a CustomerThere are many challenges facing the biotech industry today. The worldwide need for new and sophisticated healthcare products can sometimes be achieved through governmental funding sources, who are looking to solve national and international issues relating to disease, defense and future prosperity. Our panel of experts will share their experiences and how they succeeded in navigating the process, with a look from the inside—out. Don’t miss this highly informative and eye opening session. Moderator: Speaker: |
| 12:20 pm – 12:40 pm |
Break |
| 12:55 pm – 2:00 pm |
Networking Break |
| 2:00 pm – 3:00 pm |
Virtual Trade Delegation Panel DiscussionShaping Frontiers in Medical Research: New South Wales, AustraliaGlobal NSW New South Wales (NSW) is a desirable destination for clinical trials and a recognised leader in developing and delivering transformational medical treatment in both gene and cell therapy, and precision oncology through genomics and proteomics. Join our internationally recognised key opinion leaders for a panel discussion covering clinical trials capabilities, health system advantages and integration, and opportunities for partnership and investment. Moderator: Speaker: |
Monday, October 5, 2020
| 7:00 am – 7:00 pm |
BIO One-on-One Partnering Meetings open |
| 8:00 am – 5:00 pm |
Exhibit Hall Open | Networking Lounge Open |
| 9:00 am – 9:15 am |
Welcome and Opening RemarksRemarks by: |
| 9:15 am – 10:15 am |
Keynote session and Lifetime Achievement Award presentationJim Greenwood, Former President and CEO, Biotechnology Innovation Organization (BIO) Introductions by: |
| 10:15 am – 10:25 am |
Break |
| 10:25 am – 11:25 am |
SESSION ALife Sciences TrackPandemic & Risk Mitigation: A focus on preparation & resiliencyThree Maryland biotech leaders discuss how to prepare for the unforeseen and what is needed to pivot for the future. Moderator: Speakers: Entrepreneurship TrackIt Takes an EcosystemIt takes an ecosystem to generate and support entrepreneurial activities, but no two regional ecosystems are alike. A fertile entrepreneurial ecosystem is the sum of interconnected individuals, organizations and entities, a unique regional terroir that facilitates and nourishes entrepreneurial activities. Our panelists will discuss their own experience in the Biohealth Capital Region, what is unique about the Maryland ecosystem, how they have successfully leveraged local resources, tools and contacts to build and grow their business, and why they have done it in Maryland. Moderator: Speakers: |
| 11:25 am – 11:35 am |
Break |
| 11:35 am – 12:35 pm |
SESSION BLife Sciences TrackVaccine Development: Driving Partnerships in MarylandThis panel will discuss the work that each company is doing on the vaccine development front, and will highlight important partners and collaborators they have used or will be using along their path to bringing life-saving products to market. Moderator: Speakers: Entrepreneurship TrackHuman Resource as Strategy – Building a Team to Ensure Success and to Attract InvestorsAs a company progresses forward, the strategy of hiring decisions becomes paramount to their success. Value judgments must be made on how to prioritize the skills and experience necessary to attract investors. This session will discuss building a team to ensure success. It will focus on the key roles within startup companies, developing boards, what to look for when partnering with investors and other companies, and the shift of expertise when transitioning from an early stage company to a public company. Moderator: Speaker: |
| 12:35 pm – 1:50 pm |
Thought Leadership Lightning Rounds
“More Savings, More Research” BIO Business Solutions is the largest cost savings purchasing program for the life sciences industry, operated by BIO and available to members of MTC. BIO Business Solutions pools the purchasing power of thousands of life sciences companies across North America to negotiate for exclusive pricing and favorable terms on things like lab supplies, office supplies, insurance, and much more. Learn how MTC member companies can leverage the BIO Business Solutions to stretch their funding or improve their bottom line.
“The Immunology Capital Next to the Nation’s Capital: Montgomery County, MD” The epicenter for translating knowledge into previously unimaginable treatments and cures can be found in Montgomery County, Maryland next to the nation’s capital. From cell and gene therapies to vaccines, biologics and advanced biomanufacturing, global innovators with the most promising advancements in science and human health grow with us here in Maryland. In a state that’s home to the largest payer, researcher and regulator of healthcare products in the world (CMS, NIH, and FDA), Montgomery County offers access to 40,000 life sciences workers, 18 federal agency headquarters, and a prime location that features 3 international airports, extensive parkland and broad diversity in our schools and community. These resources and our prime location make Montgomery County the perfect landing spot to grow and thrive.
“Maryland Scientific Market: A 10-Year Forecast” A discussion about the expanding geography of the Maryland scientific market, major drivers, product types and cost over the next ten years.
“The Death of the Regulatory Barrier to Better Medicine” Does the development of effective drugs have to be incredibly expensive? Maybe not anymore. There is a new type of drug development emerging: Gene Therapy. The hallmark of gene therapy is the ability to edit or modify the drivers of disease at the most fundamental level, our genes. To put it simply, we now have the ability to replace a broken gene in your DNA. Those educated on the subject of gene therapy will argue that there are a thousand caveats to that sweeping statement, but those caveats are quickly eroding.
“Maintaining Continuity of Clinical Research in the era of COVID-19” COVID-19 has brought about an inflection point in our industry. Despite a brief initial slowdown in clinical trials, thousands of COVID-19 trials are on-going today, in addition to existing clinical trials. Continuing clinical research through this pandemic requires us to adopt different approaches. This session will enable you to understand what it takes to run clinical trials in this new context, where remote monitoring and virtual trials are no longer just industry buzzwords, but business as usual. |
| 2:00 pm – 3:00 pm |
Virtual Trade Delegation Panel DiscussionRegenerative Medicine & Cell Therapy Industry of Kanagawa, JapanJETRO New York Kanagawa Division Kanagawa Prefecture is one of the most dynamic life science and biotechnology hubs in Japan, home to diverse companies working on regenerative cell therapy, pharmaceuticals manufacturing, and reagent manufacturing for testing and research. This webinar will showcase the three hottest Kanagawa companies in the field of regenerative cell therapy: REPROCELL, Elixirgen Scientific, Inc. and Cyfuse Biomedical. Their deep connection to Maryland, along with Kanagawa-Maryland ties, one of the oldest US-Japan cooperative relationships, have formed a strong foundation for collaboration. Partnerships with Kanagawa affiliated companies can serve as a gateway for Maryland businesses to the vast and growing opportunities in Asian markets. Moderator: Speakers: |
| 3:00 pm – 4:00 pm |
Virtual Trade Delegation Panel DiscussionGlobal VictoriaSpeakers: |
Tuesday, October 6, 2020
| 7:00 am-7:00pm |
BIO One-on-One Partnering Meetings open |
| 8:00 am-5:00pm |
Exhibit Hall Open | Networking Lounge Open |
| 9:00 am – 10:00 am |
Keynote SpeakerFireside Chat with Senator Chris Van Hollen Join us for a fireside chat with Maryland Life Sciences CEO, Martin Rosendale, and Senator Chris Van Hollen, as they discuss the life sciences industry in Maryland, Maryland’s response to the COVID-19 pandemic and the work being done to create a more inclusive environment in industry leadership and workforce. Moderator Speaker |
| 10:00 am – 10:10 am |
Break |
| 10:10 am – 11:10 am |
SESSION CLife Sciences TrackBiomanufacturing in Maryland: Building a global footprint and maximizing the local ecosystemThe state of Maryland has over 2,700 life science firms and 500+ biotech companies. Approximately 20% of the world’s top influencers in vaccine development are in Maryland, while VC investments in life sciences companies continue to increase rapidly. In addition to the thousands of regionally anchored life sciences companies headquartered in Maryland, there are 78 federal labs driving research and innovation in the area, while many more are expanding operations in the state and advancing Maryland’s biomanufacturing footprint. This panel session will discuss biomanufacturing in the Maryland area and how the state has created a perfect formula for biomanufacturing success. Introduction by Maryland Department of Commerce Moderator Speakers
Entrepreneurship TrackBusiness Resiliency for Survival and SuccessBusiness resiliency generally implies an ability to handle unexpected, difficult situations: lack of funding, failed clinical trial, surprise FDA audit, loss of a key employee, a lawsuit, stagnant sales, etc.; but it can also mean preparedness for achieving expected goals: license in a product, raise funds, advance the product, sell the product or business, etc. In this session a panel of entrepreneurs will share advice on business resiliency based on their business experiences. Moderator Speakers |
| 11:10 am – 11:20 am |
Break |
| 11:20 am – 12:20 pm |
SESSION DLife Sciences TrackExpanding Progress and Opportunities in Gene and Cell TherapyGene and cell therapies have accrued a track record of disease treatment, IPOs on Wall Street, and transactions to large Pharma. Cures for blindness (Lebers), a deadly inherited neuronal disorder (SMA), inherited immunodeficiency (ACA-SCID and X-SCID), and cancers (AML and ALL) are early examples, but the pace of development is accelerating! Don’t miss out on the most significant future opportunities for healthcare, investment, collaboration, and career growth. Catch up on the “cutting-edge” with experts at this session. Moderator: Speaker: Entrepreneurship TrackThe Government as a CustomerThere are many challenges facing the biotech industry today. The worldwide need for new and sophisticated healthcare products can sometimes be achieved through governmental funding sources, who are looking to solve national and international issues relating to disease, defense and future prosperity. Our panel of experts will share their experiences and how they succeeded in navigating the process, with a look from the inside—out. Don’t miss this highly informative and eye opening session. Moderator: Speaker: |
| 12:20 pm – 12:40 pm |
Break |
| 12:40 pm – 12:55 pm |
Thought Leadership Lightning Rounds
|
| 12:55 pm – 2:00 pm |
Networking Break |
| 2:00 pm – 3:00 pm |
Virtual Trade Delegation Panel DiscussionShaping Frontiers in Medical Research: New South Wales, AustraliaGlobal NSW New South Wales (NSW) is a desirable destination for clinical trials and a recognised leader in developing and delivering transformational medical treatment in both gene and cell therapy, and precision oncology through genomics and proteomics. Join our internationally recognised key opinion leaders for a panel discussion covering clinical trials capabilities, health system advantages and integration, and opportunities for partnership and investment. Moderator: Speaker: |